Brain Advance Access published online on June 4, 2003
Brain, doi:10.1093/brain/awg162
© 2003 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
1 Neuromuscular Center Nijmegen, Institute of Neurology, HB Nijmegen, The Netherlands; Department of Neurology, St Elisabeth Hospital, Tilburg, The Netherlands
* Corresponding author. E-mail: b.g.m.vanengelmen{at}neuro.umcn.nl.
Received 12 November 2002
; revised 28 February 2003
; accepted 3 March 2003
Nemaline myopathy is a congenital neuromuscular disorder characterized by muscle weakness and the presence of nemaline rods. Five genes have now been associated with nemaline myopathy:
Keywords: nemaline; myopathy; genotype; core; chromosome 15
A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions
2 Neurogenetic Unit, Departments of Neurology and Anatomical Pathology, Royal Perth Hospital, Perth, Australia
3 Max-Delbrück-Centre for Molecular Medicine, Berlin, Germany
4 Neuromuscular Center Nijmegen, Institute of Neurology, HB Nijmegen, The Netherlands; Department of Pathology, University Medical Center Nijmegen, HB Nijmegen, The Netherlands
5 Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Nedlands, Western Australia, Australia
6 Department of Human Genetics, University Medical Center Nijmegen, HB Nijmegen, The Netherlands
7 Neuromuscular Center Nijmegen, Institute of Neurology, HB Nijmegen, The Netherlands; Department of Neurology, Antonius Hospital, Nieuwegein, The Netherlands
8 Neurogenetic Unit, Departments of Neurology and Anatomical Pathology, Royal Perth Hospital, Perth, Australia; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Nedlands, Western Australia, Australia
9 Neuromuscular Center Nijmegen, Institute of Neurology, HB Nijmegen, The Netherlands
10 Department of Human Genetics, University Medical Center Nijmegen, HB Nijmegen, The Netherlands; Department of Otorhinolaryngology, University Medical Center Nijmegen, HB Nijmegen, The Netherlands
-tropomyosin-3 (TPM3),
-actin (ACTA1), nebulin (NEB),
-tropomysin (TPM2) and troponin T (TNNT1). In addition, mutations in the ryanodine receptor gene (RYR1) have been associated with core-rod myopathy. Here we report linkage in two unrelated families, with a variant of nemaline myopathy, with associated core-like lesions. The clinical phenotype consists of muscle weakness in addition to a peculiar kind of muscle slowness. A genome-wide scan revealed a locus for nemaline myopathy with core-like lesions on chromosome 15q21-q23 for both families. Combining the two families gave a two-point LOD score of 10.65 for D15S993. The
-tropomyosin-1 gene (TPM1) located within this region is the strongest candidate gene. However, no mutations were found in the protein-coding region of TPM1, although small deletions or mutations in an intron cannot be excluded. The critical region contains few other candidate genes coding for muscle proteins and several genes of unknown function, and has not yet been sequenced completely. The novel phenotype of nemaline myopathy in the two presented families corresponds to an also novel, as yet uncharacterized, genotype.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A M Kaindl, F Ruschendorf, S Krause, H-H Goebel, K Koehler, C Becker, D Pongratz, J Muller-Hocker, P Nurnberg, G Stoltenburg-Didinger, et al. Missense mutations of ACTA1 cause dominant congenital myopathy with cores J. Med. Genet., November 1, 2004; 41(11): 842 - 848. [Full Text] [PDF] |
||||
